257 related articles for article (PubMed ID: 21037085)
1. Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome).
Tolar J; Park IH; Xia L; Lees CJ; Peacock B; Webber B; McElmurry RT; Eide CR; Orchard PJ; Kyba M; Osborn MJ; Lund TC; Wagner JE; Daley GQ; Blazar BR
Blood; 2011 Jan; 117(3):839-47. PubMed ID: 21037085
[TBL] [Abstract][Full Text] [Related]
2. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
3. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
Okada M; Yoneda Y
Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
[TBL] [Abstract][Full Text] [Related]
4. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
[TBL] [Abstract][Full Text] [Related]
5. Hurler disease bone marrow stromal cells exhibit altered ability to support osteoclast formation.
Gatto F; Redaelli D; Salvadè A; Marzorati S; Sacchetti B; Ferina C; Roobrouck VD; Bertola F; Romano M; Villani G; Antolini L; Rovelli A; Verfaillie CM; Biondi A; Riminucci M; Bianco P; Serafini M
Stem Cells Dev; 2012 Jun; 21(9):1466-77. PubMed ID: 22280094
[TBL] [Abstract][Full Text] [Related]
6. Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors.
Liao J; Wu Z; Wang Y; Cheng L; Cui C; Gao Y; Chen T; Rao L; Chen S; Jia N; Dai H; Xin S; Kang J; Pei G; Xiao L
Cell Res; 2008 May; 18(5):600-3. PubMed ID: 18414447
[No Abstract] [Full Text] [Related]
7. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
Heffernan C; Sumer H; Verma PJ
J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
[TBL] [Abstract][Full Text] [Related]
8. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts.
Wakao S; Kitada M; Kuroda Y; Shigemoto T; Matsuse D; Akashi H; Tanimura Y; Tsuchiyama K; Kikuchi T; Goda M; Nakahata T; Fujiyoshi Y; Dezawa M
Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9875-80. PubMed ID: 21628574
[TBL] [Abstract][Full Text] [Related]
9. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
[TBL] [Abstract][Full Text] [Related]
10. Generation of human induced pluripotent stem cell line UNIGEi001-A from a 2-years old patient with Mucopolysaccharidosis type IH disease.
Lito S; Burda P; Baumgartner M; Sloan-Béna F; Táncos Z; Kobolák J; Dinnyés A; Krause KH; Marteyn A
Stem Cell Res; 2019 Dec; 41():101604. PubMed ID: 31678774
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming of human somatic cells to pluripotency with defined factors.
Park IH; Zhao R; West JA; Yabuuchi A; Huo H; Ince TA; Lerou PH; Lensch MW; Daley GQ
Nature; 2008 Jan; 451(7175):141-6. PubMed ID: 18157115
[TBL] [Abstract][Full Text] [Related]
12. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease.
Lutzko C; Omori F; Abrams-Ogg AC; Shull R; Li L; Lau K; Ruedy C; Nanji S; Gartley C; Dobson H; Foster R; Kruth S; Dubé ID
Hum Gene Ther; 1999 Jun; 10(9):1521-32. PubMed ID: 10395377
[TBL] [Abstract][Full Text] [Related]
14. Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro.
Xia G; Santostefano K; Hamazaki T; Liu J; Subramony SH; Terada N; Ashizawa T
J Mol Neurosci; 2013 Oct; 51(2):237-48. PubMed ID: 23224816
[TBL] [Abstract][Full Text] [Related]
15. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
Cheng D; Lei L; Lu Z; Li Z; Wang H
Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
[TBL] [Abstract][Full Text] [Related]
16. Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell development.
Baxter MA; Wynn RF; Schyma L; Holmes DK; Wraith JE; Fairbairn LJ; Bellantuono I
J Inherit Metab Dis; 2005; 28(6):1045-53. PubMed ID: 16435198
[TBL] [Abstract][Full Text] [Related]
17. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
18. Efficient generation of nonhuman primate induced pluripotent stem cells.
Zhong B; Trobridge GD; Zhang X; Watts KL; Ramakrishnan A; Wohlfahrt M; Adair JE; Kiem HP
Stem Cells Dev; 2011 May; 20(5):795-807. PubMed ID: 21058905
[TBL] [Abstract][Full Text] [Related]
19. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
Takahashi K; Yamanaka S
Cell; 2006 Aug; 126(4):663-76. PubMed ID: 16904174
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells.
Seiler K; Soroush Noghabi M; Karjalainen K; Hummel M; Melchers F; Tsuneto M
Stem Cells Dev; 2011 Jul; 20(7):1131-42. PubMed ID: 21348597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
